Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9186392 Combination therapy

Patent 9186392 was granted and assigned to Boehringer Ingelheim on November, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Boehringer Ingelheim
Boehringer Ingelheim
Date Filed
May 5, 2011
Date of Patent
November 17, 2015
Patent Application Number
13695492
Patent Citations Received
‌
US Patent 11919903 Polymorphs
0
‌
US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
0
‌
US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy
0
‌
US Patent 11911445 Peptide YY pharmaceutical formulations, compositions, and methods
0
‌
US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11833248 Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9186392
Patent Primary Examiner
‌
Julie Ha

Find more entities like US Patent 9186392 Combination therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.